Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

2.51
-0.0100-0.40%
Post-market: 2.510.00000.00%16:41 EDT
Volume:199.68K
Turnover:503.68K
Market Cap:72.75M
PE:-1.03
High:2.56
Open:2.56
Low:2.50
Close:2.52
Loading ...
Apr 07, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 13, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 18, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report